Literature DB >> 15634991

Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.

Masaki Takahashi1, Michiaki Koga, Keiko Yokoyama, Nobuhiro Yuki.   

Abstract

Campylobacter jejuni isolation is the standard for the diagnosis of this type of bacterial infection, but there have been no epidemiological studies of a large number of C. jejuni isolates from patients with Guillain-Barre syndrome (GBS) and Fisher syndrome (FS). For 13 years, stool specimens from GBS/FS patients have been sent from 378 hospitals throughout Japan to the Tokyo Metropolitan Institute of Public Health. A total of 113 strains (11%) were isolated from the stool specimens from 1,049 patients. The isolation rate did not differ by region. The rates were 22% for 449 patients with a history of diarrhea and 2% for the others. An additional 18 isolates were provided by various hospitals. There was no noticeable seasonal distribution in the onset of C. jejuni isolated from patients with GBS/FS. The male/female ratios were 1.7:1 for GBS and 2.2:1 for FS. The patient age range showed a peak in 10- to 30-year-old subjects who had GBS and in 10- to 20-year-old subjects who had FS. The predominance of young adults and male patients who had C. jejuni-associated GBS/FS may be related to the preponderance of young adults and male patients who had C. jejuni enteritis. The median interval from diarrhea onset to neurologic symptom onset was 10 days for GBS/FS. Penner's C. jejuni serotype HS:19 was more frequently present in GBS (67%) than in enteritis (6%) patients. HS:2 was more frequent in FS (41%) than in enteritis (14%) patients. These findings suggest that certain C. jejuni strains specifically trigger GBS and that others specifically trigger FS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634991      PMCID: PMC540119          DOI: 10.1128/JCM.43.1.335-339.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  A Campylobacter jejuni gene associated with immune-mediated neuropathy.

Authors:  A van Belkum; N van den Braak; P Godschalk; W Ang; B Jacobs; M Gilbert; W Wakarchuk; H Verbrugh; H Endtz
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

2.  Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

3.  Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis.

Authors:  I Nachamkin; J Engberg; M Gutacker; R J Meinersman; C Y Li; P Arzate; E Teeple; V Fussing; T W Ho; A K Asbury; J W Griffin; G M McKhann; J C Piffaretti
Journal:  J Infect Dis       Date:  2001-06-08       Impact factor: 5.226

4.  Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis.

Authors:  J Engberg; I Nachamkin; V Fussing; G M McKhann; J W Griffin; J C Piffaretti; E M Nielsen; P Gerner-Smidt
Journal:  J Infect Dis       Date:  2001-06-08       Impact factor: 5.226

5.  Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.

Authors:  N Yuki; M Yamada; M Koga; M Odaka; K Susuki; Y Tagawa; S Ueda; T Kasama; A Ohnishi; S Hayashi; H Takahashi; M Kamijo; K Hirata
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

Review 6.  Clinical and epidemiologic features of Guillain-Barré syndrome.

Authors:  R A Hughes; J H Rees
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

7.  Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome.

Authors:  S Fujimoto; B M Allos; N Misawa; C M Patton; M J Blaser
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

8.  Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.

Authors:  Q Hao; T Saida; S Kuroki; M Nishimura; M Nukina; H Obayashi; K Saida
Journal:  J Neuroimmunol       Date:  1998-01       Impact factor: 3.478

9.  Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.

Authors:  M Koga; N Yuki; M Takahashi; K Saito; K Hirata
Journal:  J Neuroimmunol       Date:  1998-01       Impact factor: 3.478

10.  The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study.

Authors:  B C Jacobs; P H Rothbarth; F G van der Meché; P Herbrink; P I Schmitz; M A de Klerk; P A van Doorn
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

View more
  21 in total

Review 1.  Colonization properties of Campylobacter jejuni in chickens.

Authors:  C Pielsticker; G Glünder; S Rautenschlein
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-03-17

2.  Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.

Authors:  Michiaki Koga; Masaki Takahashi; Keiko Yokoyama; Takashi Kanda
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

3.  Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome.

Authors:  Valérie Sivadon-Tardy; David Orlikowski; Raphael Porcher; Esthel Ronco; Christiane Caudie; Jacqueline Roussi; Jean-Louis Fauchère; Francis Mégraud; Helen Tabor; Tarek Sharshar; Djillali Annane; Jean-Claude Raphaël; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2010-04-21       Impact factor: 5.948

4.  Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations.

Authors:  Craig T Parker; Michel Gilbert; Nobuhiro Yuki; Hubert P Endtz; Robert E Mandrell
Journal:  J Bacteriol       Date:  2008-06-13       Impact factor: 3.490

Review 5.  Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.

Authors:  Brian L Pike; Patricia Guerry; Frédéric Poly
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

6.  Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.

Authors:  Eduardo N Taboada; Alex van Belkum; Nobuhiro Yuki; Rey R Acedillo; Peggy Cr Godschalk; Michiaki Koga; Hubert P Endtz; Michel Gilbert; John He Nash
Journal:  BMC Genomics       Date:  2007-10-05       Impact factor: 3.969

Review 7.  Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.

Authors:  Nobuhiro Yuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

8.  Binational outbreak of Guillain-Barré syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011.

Authors:  B R Jackson; J Alomía Zegarra; H López-Gatell; J Sejvar; F Arzate; S Waterman; A Sánchez Núñez; B López; J Weiss; R Quintero Cruz; D Y López Murrieta; R Luna-Gierke; K Heiman; A R Vieira; C Fitzgerald; P Kwan; M Zárate-Bermúdez; D Talkington; V R Hill; B Mahon
Journal:  Epidemiol Infect       Date:  2013-08-07       Impact factor: 4.434

9.  Comparative genomic analysis of clinical strains of Campylobacter jejuni from South Africa.

Authors:  Beatriz Quiñones; Magalie R Guilhabert; William G Miller; Robert E Mandrell; Albert J Lastovica; Craig T Parker
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

10.  Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005.

Authors:  Ji-Rong Yang; Ho-Sheng Wu; Chuen-Sheue Chiang; Jung-Jung Mu
Journal:  BMC Infect Dis       Date:  2008-10-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.